Altair Nanotechnologies Names John Fallini CFO.

RENO, Nev. -- Altair Nanotechnologies Inc. (Altairnano) (Nasdaq: ALTI), a leading provider of advanced nanomaterials technology for use in energy, pharmaceutical, life sciences and industrial applications, today named John C. Fallini as its chief financial officer. Mr. Fallini replaces Edward C. Dickinson, who will remain with the company in the newly created position of Senior Director Programs and Contracts. Mr. Dickinson will also retain the position of Corporate Secretary.

In his new position, Mr. Dickinson will be responsible for assuring that key development and business programs and strategy are properly implemented and executed and meet the standards and expectations set by the company and its customers.

"Ed Dickinson has been with the company since 1996. His broad experience, knowledge and contacts are invaluable to the continued growth and success of Altairnano, and I am pleased to have him continue in this important new role," said Terry Copeland, the company's interim president.

Mr. Fallini joins Altairnano from Alloptic, Inc., a producer of passive optical network access equipment for the telecommunications industry, where he served as chief financial officer. Prior to his tenure at Alloptic, Mr. Fallini held management positions at three technology companies, including Pacific Bell, where he held various executive and management positions between 1976 and 1998. From 1998 to 2000, he was the chief operating officer at Butterfield & Butterfield, the then privately owned auction house, during its proposed IPO filing and subsequent sale to eBay for $260 million in 1999.

"As Altairnano transitions from technology and product development to manufacturing, we are fortunate to have a CFO whose background includes not only finance, but the administrative and infrastructure functions that enable management to more effectively manage the transition.

"John has extensive experience with companies that have developed sophisticated technology into marketable products for a range of customers," Mr. Copeland continued. "This will become increasingly important for Altairnano as new applications for our core technology are developed and relationships with customers take on increased importance to our success.

"John has repeatedly worked through issues of product pricing, customer contract costing, financial risk and cash management that are critical to any company, but particularly one like Altairnano as it continues to move from a development and design environment to manufacturing. I am very pleased that he has accepted our offer to become CFO."

Mr. Fallini graduated Cum Laude with a Bachelor of Science degree in engineering and applied science from UCLA, and earned an MBA in finance from Oklahoma City University, where he graduated with high honors. He is a member of the Institute of Management Accountants (IMA) and an IMA Certified Management Accountant.

About Altair Nanotechnologies Inc.

Altairnano is an innovator and supplier of advanced novel, ceramic nanomaterials. A seasoned management team complements Altairnano's leading edge scientists, with substantial experience in commercializing innovative, disruptive technologies. The company has developed nanomaterials for the alternative energy, life sciences and performance materials markets based on its proprietary manufacturing process. This process also provides the foundation for its innovative AHP pigment process. For more information visit www.altairnano.com.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the Altairnano's actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the risks that development of the products referenced in this release will not be completed for technical, business or other reasons and that any products under development or in the early commercial stages will not perform as expected in future testing or commercial applications or will not readily find market acceptance. In general, Altairnano is, and expects to be in the immediate future, dependent upon funds generated from sales of securities, grants, testing agreements, and licensing agreements to fund its testing, development and ongoing operations. In addition, other risks are identified in the company's most recent Annual Report on Form 10-K filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.